ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer.

Julia K Rotow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.